A homologous series of mono-and bis-acyl polyamines with varying acyl chain lengths originally synthesized for the purpose of sequestering lipopolysaccharide were evaluated for antimicrobial activity to test the hypothesis that these bis-cationic amphipathic compounds may also bind to and permeabilize intact gramnegative bacterial membranes. Some compounds were found to possess significant antimicrobial activity, mediated via permeabilization of bacterial membranes. Structure-activity relationship studies revealed a strong dependence of the acyl chain length on antimicrobial potency and permeabilization activity. Homologated spermine, bis-acylated with C 8 or C 9 chains, was found to profoundly sensitize Escherichia coli to hydrophobic antibiotics such as rifampin. Nonspecific cytotoxicity is a potential drawback of these membranophilic compounds. However, the surface activity of these cationic amphipaths is strongly attenuated under physiological conditions via binding to serum albumin. Significant antibacterial activity is still retained in the presence of physiological concentrations of human serum albumin, suggesting that these compounds may serve as leads in the development of novel adjuncts to conventional antimicrobial chemotherapy.The accelerated emergence of many strains of multidrugresistant bacteria as a result of widespread use and misuse of antibiotics has mandated the urgent need for a renewed search for novel antibacterial agents. The presence of an outer membrane (OM) in gram-negative bacteria provides an effective protective barrier in these organisms (33, 34) to antimicrobial agents that may otherwise be active. For instance, it has been reported that in antibiotics of natural origin that are active against gram-positive bacteria, more than 90% lacked activity at a useful level against Escherichia coli (55). The barrier, formed by a divalent cation-cross-linked matrix (36, 40) of lipopolysaccharide (LPS) molecules on the outer leaflet of the OM (17, 48), can be breached by metal-chelating agents such as EDTA or via displacement of LPS-bound metals by polycations of diverse structural classes (20,36,40,54,57).Polymyxin B (PMB), a cyclic, pentacationic, amphipathic peptide antibiotic isolated from Bacillus polymyxa (49) is a prototype membrane-perturbing agent whose antibacterial action is manifested via its binding to the lipid A moiety of LPS. Perturbation of the OM alone has been thought to result in bacterial killing, since immobilized PMB can disrupt the OM (41); however, alternate hypotheses concerning "self-promoted" uptake of the antibiotic and subsequent perturbation of the inner membrane (IM), culminating in bacterial lysis, have also been suggested (11, 64). The recognition that membrane-active antimicrobials have not yet been exploited adequately in the clinic has spurred the search for noncytolytic, selective bacterial membrane-permeabilizing agents, notable examples of which include cationic peptides (18,19) and smallmolecule PMB mimics (12,13,27,44). The use of cationic peptides as...